Opioid-induced hyperalgesia in community-dwelling adults with chronic pain
- PMID: 25815431
- PMCID: PMC4431900
- DOI: 10.1097/j.pain.0000000000000170
Opioid-induced hyperalgesia in community-dwelling adults with chronic pain
Abstract
The hyperalgesic effects of long-term opioid use in community-dwelling adults with chronic pain have not been widely reported. Therefore, the primary aim of this study was to determine the associations between opioid use and heat pain (HP) perception in a sample of community-dwelling adults with chronic pain. The study cohort involved 187 adults (85 opioid and 102 nonopioid) with chronic pain consecutively admitted to an outpatient interdisciplinary pain treatment program. Heat pain perception was assessed using a validated quantitative sensory test method of levels. An effect of opioid use was observed for nonstandardized (P = 0.004) and standardized (P = 0.005) values of HP 5-0.5 in which values of the opioid group were lower (more hyperalgesic) compared with those of the nonopioid group. HP 5-0.5 is a measure of the slope of the line connecting HP 0.5 (HP threshold) and HP 5 (intermediate measure of HP tolerance). In univariable (P = 0.019) and multiple variable (P = 0.003) linear regression analyses (adjusted for age, sex, body mass index, work status, pain diagnosis, pain severity, depression, and pain catastrophizing), opioid use was associated with lower (more hyperalgesic) nonstandardized values of HP 5-0.5. Similarly, in univariable (P = 0.004) and multiple variable (P = 0.011) linear regression analyses (adjusted for work status, pain diagnosis, pain severity, depression, and pain catastrophizing), opioid use was associated with lower standardized values of HP 5-0.5. In this sample of community-dwelling adults, these observations suggest that long-term opioid use was associated with hyperalgesia independent of other clinical factors known to influence HP perception.
Figures
Similar articles
-
Pain Catastrophizing and Anxiety are Associated With Heat Pain Perception in a Community Sample of Adults With Chronic Pain.Clin J Pain. 2016 Oct;32(10):875-81. doi: 10.1097/AJP.0000000000000333. Clin J Pain. 2016. PMID: 26626297
-
Effect of catechol-O-methyltransferase (rs4680) single-nucleotide polymorphism on opioid-induced hyperalgesia in adults with chronic pain.Mol Pain. 2019 Jan-Dec;15:1744806919848929. doi: 10.1177/1744806919848929. Mol Pain. 2019. PMID: 31041874 Free PMC article.
-
Hyperalgesia induced by low-dose opioid treatment before orthopaedic surgery: An observational case-control study.Eur J Anaesthesiol. 2015 Apr;32(4):255-61. doi: 10.1097/EJA.0000000000000197. Eur J Anaesthesiol. 2015. PMID: 25485877
-
Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis.Br J Anaesth. 2019 Jun;122(6):e114-e126. doi: 10.1016/j.bja.2018.09.019. Epub 2018 Oct 25. Br J Anaesth. 2019. PMID: 30915985
-
Serotonin-1A receptor dependent modulation of pain and reward for improving therapy of chronic pain.Pharmacol Res. 2018 Aug;134:212-219. doi: 10.1016/j.phrs.2018.06.030. Epub 2018 Jun 30. Pharmacol Res. 2018. PMID: 29969666 Review.
Cited by
-
Medical Use of Long-term Extended-release Opioid Analgesics in Commercially Insured Adults in the United States.Pain Med. 2020 Apr 1;21(4):724-735. doi: 10.1093/pm/pnz155. Pain Med. 2020. PMID: 31340004 Free PMC article.
-
Factors influencing pain medication and opioid use in patients with musculoskeletal injuries: a retrospective insurance claims database study.Sci Rep. 2024 Jan 23;14(1):1978. doi: 10.1038/s41598-024-52477-7. Sci Rep. 2024. PMID: 38263185 Free PMC article.
-
Opioid-induced constipation: advances and clinical guidance.Ther Adv Chronic Dis. 2016 Mar;7(2):121-34. doi: 10.1177/2040622315627801. Epub 2016 Jan 25. Ther Adv Chronic Dis. 2016. PMID: 26977281 Free PMC article. Review.
-
Contemporaneous Link Between Pain and Craving in Patients Recovering from Prescription Opioid Use Disorder During Residential Treatment.Subst Use Misuse. 2025;60(7):978-988. doi: 10.1080/10826084.2025.2478590. Epub 2025 Mar 20. Subst Use Misuse. 2025. PMID: 40114409
-
Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations.CNS Drugs. 2015 Jun;29(6):465-86. doi: 10.1007/s40263-015-0255-x. CNS Drugs. 2015. PMID: 26142224 Review.
References
-
- Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M. Short-term infusion of the muopioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain. 2003;106:49–57. - PubMed
-
- Backonja MM, Walk D, Edwards RR, Sehgal N, Moeller-Bertram T, Wasan A, Irving G, Argoff C, Wallace M. Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities. Clin J Pain. 2009;25:641–7. - PubMed
-
- Bernstein IH, Jaremko ME, Hinkley BS. On the utility of the West Haven-Yale Multidimensional Pain Inventory. Spine (Phila Pa 1976) 1995;20:956–63. - PubMed
-
- Boettger MK, Grossmann D, Bar KJ. Thresholds and perception of cold pain, heat pain, and the thermal grill illusion in patients with major depressive disorder. Psychosom Med. 2013;75:281–7. - PubMed
-
- Celerier E, Laulin J, Larcher A, Le Moal M, Simonnet G. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats. Brain Res. 1999;847:18–25. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous